ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...

Shares edge higher; gold stocks bounce back; Westpac tips 25bps May cut, fears tariff fallout; Resmed, Tesla rally; gold ...

Shares edge higher; Trump to reportedly wind down tariff rate on China; Tesla leaps 5pc; ResMed evades trade war blow; iron ...

It was yet another strong quarter from this high-quality company. The post ResMed shares jump 8% on strong Q3 update appeared ...

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year ...

Morgans senior healthcare analyst Scott Power says healthcare stocks have had a strong start to the latest reporting season.

Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...

Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment communitySAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: ...

In the assessment of 12-month price targets, analysts unveil insights for ResMed, presenting an average target of $267.0, a ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

The risk of both all-cause deaths and those caused by cardiovascular conditions in OSA patients is significantly reduced with the use of CPAP therapy.